embB306 mutations as molecular indicators to predict ethambutol susceptibility in Mycobacterium tuberculosis.
about
The rationale for using rifabutin in the treatment of MDR and XDR tuberculosis outbreaksWhole genome sequencing based characterization of extensively drug-resistant Mycobacterium tuberculosis isolates from PakistanRe-evaluation of the critical concentration for ethambutol antimicrobial sensitivity testing on the MGIT 960.Evaluation of a microcolony growth monitoring method for the rapid determination of ethambutol resistance in Mycobacterium tuberculosisAssessment of a 96-Well Plate Assay of Quantitative Drug Susceptibility Testing for Mycobacterium Tuberculosis Complex in China.Revisiting the mutant prevention concentration to guide dosing in childhood tuberculosis.
P2860
embB306 mutations as molecular indicators to predict ethambutol susceptibility in Mycobacterium tuberculosis.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
embB306 mutations as molecular ...... in Mycobacterium tuberculosis.
@en
embB306 mutations as molecular ...... in Mycobacterium tuberculosis.
@nl
type
label
embB306 mutations as molecular ...... in Mycobacterium tuberculosis.
@en
embB306 mutations as molecular ...... in Mycobacterium tuberculosis.
@nl
prefLabel
embB306 mutations as molecular ...... in Mycobacterium tuberculosis.
@en
embB306 mutations as molecular ...... in Mycobacterium tuberculosis.
@nl
P2093
P2860
P356
P1433
P1476
embB306 mutations as molecular ...... in Mycobacterium tuberculosis.
@en
P2093
Erik C Böttger
Frederick A Sirgel
Paul D van Helden
Thomas C Victor
P2860
P304
P356
10.1159/000343474
P577
2012-11-17T00:00:00Z